Enlaza

Covalent Biologics

Enlaza Therapeutics is pioneering the field of covalent biologics. They have developed a proprietary platform called War-Lock™ that enables the creation of novel protein therapeutics with the ability to irreversibly form covalent bonds to disease related target proteins. Enlaza couples their novel synthetic biology platform with proprietary amino acids to develop precision-engineer biological medicine. Enlaza Therapeutics is focused on developing covalent biologic drugs for various therapeutic areas, including oncology. Their pipeline includes several promising candidates targeting undruggable or difficult-to-drug targets.